RxSight, Inc. Cost of Revenue
RxSight, Inc. (RXST) reported Cost of Revenue of $7.86 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- RxSight, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $7.86M, a 7.01% decline year-over-year.
- RxSight, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $7.39M, a 22.69% decline year-over-year.
- RxSight, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $7.34M, a 35.72% decline year-over-year.
- RxSight, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $6.11M, a 39.44% decline year-over-year.
- RxSight, Inc. cost of goods and services sold for fiscal 2025 was $31.47M, a 23.21% decline from fiscal 2024.
- RxSight, Inc. cost of goods and services sold for fiscal 2024 was $40.98M, a 16.06% increase from fiscal 2023.
- RxSight, Inc. cost of goods and services sold for fiscal 2023 was $35.31M, a 27.59% increase from fiscal 2022.
- RxSight, Inc. cost of goods and services sold for fiscal 2022 was $27.68M, a 53.11% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.86M 10-Q · filed 2026-08-05 | $15.25M 10-Q · filed 2026-08-05 | $22.59M derived: sum of 3 quarters · filed 2026-08-05 | $28.71M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $7.39M 10-Q · filed 2026-05-06 | $14.74M derived: sum of 2 quarters · filed 2026-05-06 | $20.85M derived: sum of 3 quarters · filed 2026-05-06 | $29.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.46M derived: sum of 2 quarters · filed 2026-02-25 | $21.91M derived: sum of 3 quarters · filed 2026-08-05 | $31.47M 10-K · filed 2026-02-25 |
| 2025-09-30 | $6.11M 10-Q · filed 2025-11-05 | $14.56M derived: sum of 2 quarters · filed 2026-08-05 | $24.13M 10-Q · filed 2025-11-05 | $35.55M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $8.45M 10-Q · filed 2026-08-05 | $18.01M 10-Q · filed 2026-08-05 | $29.44M derived: sum of 3 quarters · filed 2026-08-05 | $39.53M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $9.57M 10-Q · filed 2026-05-06 | $20.99M derived: sum of 2 quarters · filed 2026-05-06 | $31.09M derived: sum of 3 quarters · filed 2026-05-06 | $41.72M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $21.52M derived: sum of 2 quarters · filed 2026-02-25 | $32.16M derived: sum of 3 quarters · filed 2026-02-25 | $40.98M 10-K · filed 2026-02-25 |
| 2024-09-30 | $10.09M 10-Q · filed 2025-11-05 | $20.73M derived: sum of 2 quarters · filed 2025-11-05 | $29.56M 10-Q · filed 2025-11-05 | $40.48M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $10.64M 10-Q · filed 2025-08-07 | $19.46M 10-Q · filed 2025-08-07 | $30.39M derived: sum of 3 quarters · filed 2026-02-25 | $38.86M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $8.83M 10-Q · filed 2025-05-07 | $19.75M derived: sum of 2 quarters · filed 2026-02-25 | $28.22M derived: sum of 3 quarters · filed 2026-02-25 | $37.02M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $10.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $19.39M derived: sum of 2 quarters · filed 2026-02-25 | $28.19M derived: sum of 3 quarters · filed 2026-02-25 | $35.31M 10-K · filed 2026-02-25 |
| 2023-09-30 | $8.47M 10-Q · filed 2024-11-07 | $17.26M derived: sum of 2 quarters · filed 2024-11-07 | $24.39M 10-Q · filed 2024-11-07 | $33.05M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $8.79M 10-Q · filed 2024-08-05 | $15.92M 10-Q · filed 2024-08-05 | $24.58M derived: sum of 3 quarters · filed 2025-02-25 | $31.84M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $7.12M 10-Q · filed 2024-05-06 | $15.79M derived: sum of 2 quarters · filed 2025-02-25 | $23.05M derived: sum of 3 quarters · filed 2025-02-25 | $29.62M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $8.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $15.93M derived: sum of 2 quarters · filed 2025-02-25 | $22.50M derived: sum of 3 quarters · filed 2025-02-25 | $27.68M 10-K · filed 2025-02-25 |
| 2022-09-30 | $7.26M 10-Q · filed 2023-11-09 | $13.83M derived: sum of 2 quarters · filed 2023-11-09 | $19.01M 10-Q · filed 2023-11-09 | $24.57M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $6.57M 10-Q · filed 2023-08-07 | $11.75M 10-Q · filed 2023-08-07 | $17.31M derived: sum of 3 quarters · filed 2023-08-07 | $21.75M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $5.18M 10-Q · filed 2023-05-09 | $10.74M derived: sum of 2 quarters · filed 2023-05-09 | $15.18M derived: sum of 3 quarters · filed 2023-05-09 | $20.89M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $5.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $10.00M derived: sum of 2 quarters · filed 2023-03-06 | $15.71M derived: sum of 3 quarters · filed 2023-03-06 | $18.08M 10-K · filed 2023-03-06 |
| 2021-09-30 | $4.45M 10-Q · filed 2022-11-07 | $10.15M derived: sum of 2 quarters · filed 2022-11-07 | $12.52M 10-Q · filed 2022-11-07 | $16.05M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $5.71M 10-Q · filed 2022-08-08 | $8.07M 10-Q · filed 2022-08-08 | $11.61M derived: sum of 3 quarters · filed 2022-08-08 | $15.06M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $2.37M 10-Q · filed 2022-05-05 | $5.90M derived: sum of 2 quarters · filed 2022-05-05 | $9.35M derived: sum of 3 quarters · filed 2022-05-05 | $12.53M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $6.98M derived: sum of 2 quarters · filed 2022-03-08 | $10.16M derived: sum of 3 quarters · filed 2022-03-08 | $12.97M 10-K · filed 2022-03-08 |
| 2020-09-30 | $3.45M 10-Q · filed 2021-11-10 | $6.63M derived: sum of 2 quarters · filed 2021-11-10 | $9.44M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $3.18M 10-Q · filed 2021-09-09 | $5.99M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |